Pfizer predicts that a fourth dose of a COVID-19 vaccine may be needed to quell the Omicron variant; CMS officials share figures on enrollment for health coverage under the Affordable Care Act (ACA); City of Hope announces acquisition of Cancer Treatment Centers of America.
Executives at Pfizer, the maker of the first FDA-approved vaccine against COVID-19, said that the presence of the new Omicron variant could increase the likelihood that people will need a fourth dose of a vaccine earlier than expected, according to a report from The Washington Post. Previously the company’s CEO, Albert Bourla, projected that a fourth dose of a COVID-19 vaccine may be needed 12 months after a person receives their third dose, but the spread of Omicron may require the timeline to be pushed up. As of December 9, over 40 people in the United States have tested positive for the new variant, all of whom have shown mild symptoms, and the variant is present in 57 countries.
CMS and HHS announced that almost 4.6 million people signed up for health care coverage during the open enrollment period on HealthCare.gov, the website used to register for health coverage under the Affordable Care Act (ACA), and state-based marketplaces. Additionally, the assistance from the American Rescue Plan continued to drive down health care costs, with 95% of consumers receiving premium tax credits to lower monthly premium costs, and the number of consumers receiving coverage for $10 or less per month after tax credits nearly doubling compared with 2020. Plan selections in the 33 HealthCare.gov states are up 5% since 2020 and nearly 2.8 million people newly gained access to affordable health care coverage during the 2021 Special Enrollment Period, officials said.
City of Hope, a comprehensive cancer research and treatment organization, announced that it has entered into a definitive agreement to acquire Cancer Treatment Centers of America, a network of oncology hospitals and outpatient care centers. The acquisition expands and accelerates City of Hope’s ability to rapidly translate research and science into cancer care and expands the organization’s portfolio, reach, and impact of cancer services and capabilities, including research and development, into more communities nationwide. Combined, the organizations will include approximately 11,000 team members, including 575 physicians across California, Arizona, Illinois, and Georgia.
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Contributor: For Complex Cases, Continuity in Acute Care Is Necessary
April 23rd 2025For patients with complex needs and social challenges like unstable housing, the hospital has become their de facto medical home—yet each visit is a fragmented restart, without continuity, context, or a clear path forward.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Contributor: For Complex Cases, Continuity in Acute Care Is Necessary
April 23rd 2025For patients with complex needs and social challenges like unstable housing, the hospital has become their de facto medical home—yet each visit is a fragmented restart, without continuity, context, or a clear path forward.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
2 Commerce Drive
Cranbury, NJ 08512